SE463715B - Psykogeriatriska 1-(2-pyrimidinyl)-piperazinyl-derivat av 1-pyrrolidin-2-oner och foerfarande foer framstaellning av dessa - Google Patents

Psykogeriatriska 1-(2-pyrimidinyl)-piperazinyl-derivat av 1-pyrrolidin-2-oner och foerfarande foer framstaellning av dessa

Info

Publication number
SE463715B
SE463715B SE8503557A SE8503557A SE463715B SE 463715 B SE463715 B SE 463715B SE 8503557 A SE8503557 A SE 8503557A SE 8503557 A SE8503557 A SE 8503557A SE 463715 B SE463715 B SE 463715B
Authority
SE
Sweden
Prior art keywords
pyrimidinyl
lower alkyl
hydrogen
formula
piperazinyl
Prior art date
Application number
SE8503557A
Other languages
English (en)
Swedish (sv)
Other versions
SE8503557D0 (sv
SE8503557L (sv
Inventor
J P Yevich
R J Mattson
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SE8503557D0 publication Critical patent/SE8503557D0/xx
Publication of SE8503557L publication Critical patent/SE8503557L/xx
Publication of SE463715B publication Critical patent/SE463715B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8503557A 1984-07-23 1985-07-22 Psykogeriatriska 1-(2-pyrimidinyl)-piperazinyl-derivat av 1-pyrrolidin-2-oner och foerfarande foer framstaellning av dessa SE463715B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63337184A 1984-07-23 1984-07-23

Publications (3)

Publication Number Publication Date
SE8503557D0 SE8503557D0 (sv) 1985-07-22
SE8503557L SE8503557L (sv) 1986-01-24
SE463715B true SE463715B (sv) 1991-01-14

Family

ID=24539376

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8503557A SE463715B (sv) 1984-07-23 1985-07-22 Psykogeriatriska 1-(2-pyrimidinyl)-piperazinyl-derivat av 1-pyrrolidin-2-oner och foerfarande foer framstaellning av dessa

Country Status (8)

Country Link
JP (1) JPS61106570A (fr)
CA (1) CA1250291A (fr)
DK (1) DK333485A (fr)
FR (1) FR2567886B1 (fr)
GB (1) GB2162843B (fr)
HU (1) HU194874B (fr)
IT (1) IT1187699B (fr)
SE (1) SE463715B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1322199C (fr) * 1987-07-15 1993-09-14 Masami Eigyo Derives n-(2 oxopyrrolidin-1-yl) acetylpiperazine et medicaments pour la demence senile
EP0395312B1 (fr) * 1989-04-22 1999-05-12 JOHN WYETH & BROTHER LIMITED Dérivés de pipérazine
US5340812A (en) * 1989-04-22 1994-08-23 John Wyeth & Brother, Limited Piperazine derivatives
GB8917687D0 (en) * 1989-08-02 1989-09-20 Fujisawa Pharmaceutical Co Aminopiperazine derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
US5250528A (en) * 1989-08-02 1993-10-05 Fujisawa Pharmaceutical Co., Ltd. New aminopiperazine derivatives
US6355800B1 (en) 1997-10-09 2002-03-12 Fujisawa Pharmaceutical Co., Ltd. Process for producing aminopiperazine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
DE3361609D1 (en) * 1982-03-24 1986-02-06 Prodes Sa New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts

Also Published As

Publication number Publication date
JPS61106570A (ja) 1986-05-24
GB2162843B (en) 1988-04-20
CA1250291A (fr) 1989-02-21
HUT38342A (en) 1986-05-28
IT1187699B (it) 1987-12-23
GB2162843A (en) 1986-02-12
SE8503557D0 (sv) 1985-07-22
DK333485D0 (da) 1985-07-22
FR2567886B1 (fr) 1988-03-25
DK333485A (da) 1986-01-24
SE8503557L (sv) 1986-01-24
HU194874B (en) 1988-03-28
GB8518452D0 (en) 1985-08-29
FR2567886A1 (fr) 1986-01-24
IT8521657A0 (it) 1985-07-22

Similar Documents

Publication Publication Date Title
US4668687A (en) Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
US4524206A (en) 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US5015741A (en) Nicotine analogs
JPH0236159A (ja) 化学化合物類
JPH01249769A (ja) 向精神性ヘテロビシクロアルキルピペラジン誘導体
HU178362B (en) Process for preparing lactam-n-acetic acids and amides thereof
SE463715B (sv) Psykogeriatriska 1-(2-pyrimidinyl)-piperazinyl-derivat av 1-pyrrolidin-2-oner och foerfarande foer framstaellning av dessa
DK170441B1 (da) Diazinylpiperidinderivater af cykliske amider og imider, samt fremgangsmåde til fremstilling deraf
IE920036A1 (en) New benzisoxazole and benzisothiazole compounds, process for the preparation thereof, and pharmaceutical compositions containing them
US5449677A (en) Cyclic benzylamino, benzylamido and benzylimido antipsychotic agents
US4826843A (en) Cerebral function enhancing diazinylpiperidine derivatives
US4992441A (en) 1-[[5-[[4-substituted-1-piperazinyl]methyl]-pyrrol-2-yl or furan-2-yl]methyl-2-piperidinones useful in treating schizophrenia
US4492696A (en) Piperazine and homopiperazine compounds
HU191075B (en) Process for preparing new derivatives of /3/6-fluoro-1,2-benzisoxazol-3-yl/-propyl/-piperazine and - piperidine and pharmaceutical compositions containing thereof
US5138062A (en) Nicotine analogs
DE68907845T2 (de) Verbrückte bicyclische 4-(4-(3-Benzisothiazolyl)-1-piperazinyl)-butylimide mit antipsychotischer Wirkung.
KR100302216B1 (ko) 새로운니코틴산에스테르화합물및그제조방법
KR20080027925A (ko) 신규한 1ｈ­인돌­피리딘카르복스아미드 유도체 및1ｈ­인돌­피페리딘카르복스아미드 및 이들의히드록실라아제 티로신 유도제로서의 용도
CA1077485A (fr) Derives 4-amino des acides 2h-pyrazolo (3,4-b) pyridine-5-carboxyliques et de leurs esters
JPH045675B2 (fr)

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8503557-4

Effective date: 19920210

Format of ref document f/p: F